1	Host-derived	Host-derived	B-NP	JJ	O	2	NMOD	0
2	angiopoietin-2	angiopoietin-2	I-NP	NN	O	3	SUB	0
3	affects	affect	B-VP	VBZ	O	0	ROOT	16	affects
4	early	early	B-NP	JJ	O	5	NMOD	0
5	stages	stage	I-NP	NNS	O	3	OBJ	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	tumor	tumor	B-NP	NN	O	8	NMOD	0
8	development	development	I-NP	NN	O	11	NMOD	2	development
9	and	and	O	CC	O	11	NMOD	0
10	vessel	vessel	B-NP	NN	O	11	NMOD	0
11	maturation	maturation	I-NP	NN	O	6	PMOD	2	maturation
12	but	but	O	CC	O	3	VMOD	0
13	is	be	B-VP	VBZ	O	3	VMOD	0
14	dispensable	dispensable	B-ADJP	JJ	O	13	PRD	16	dispensable
15	for	for	B-PP	IN	O	14	AMOD	0
16	later	later	B-NP	JJ	O	17	NMOD	0
17	stages	stage	I-NP	NNS	O	15	PMOD	0
18	of	of	B-PP	IN	O	17	NMOD	0
19	tumor	tumor	B-NP	NN	O	20	NMOD	0
20	growth	growth	I-NP	NN	O	18	PMOD	4	growth
21	.	.	O	.	O	3	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	angiopoietin/Tie2	angiopoietin/Tie2	I-NP	NN	O	3	NMOD	0
3	system	system	I-NP	NN	O	4	SUB	0
4	has	have	B-VP	VBZ	O	0	ROOT	0
5	been	be	I-VP	VBN	O	4	VC	0
6	identified	identify	I-VP	VBN	O	5	VC	0
7	as	as	B-PP	IN	O	6	VMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	second	second	I-NP	JJ	O	14	NMOD	0
10	vascular-specific	vascular-specific	I-NP	JJ	B-protein	14	NMOD	0
11	receptor	receptor	I-NP	NN	I-protein	14	NMOD	0
12	tyrosine	tyrosine	I-NP	NN	I-protein	14	NMOD	0
13	kinase	kinase	I-NP	NN	I-protein	14	NMOD	0
14	system	system	I-NP	NN	O	7	PMOD	0
15	controlling	control	B-VP	VBG	O	14	NMOD	16	controlling
16	vessel	vessel	B-NP	NN	O	17	NMOD	0
17	assembly	assembly	I-NP	NN	O	22	NMOD	2	assembly
18	,	,	O	,	O	22	P	0
19	maturation	maturation	B-NP	NN	O	22	NMOD	2	maturation
20	,	,	O	,	O	22	P	0
21	and	and	O	CC	O	22	NMOD	0
22	quiescence	quiescence	B-NP	NN	O	15	OBJ	2	quiescence
23	.	.	O	.	O	4	P	0

1	Angiopoietin-2	Angiopoietin-2	B-NP	NN	B-protein	5	SUB	0
2	(	(	O	(	O	4	DEP	0
3	Ang-2	Ang-2	B-NP	NN	B-protein	4	DEP	0
4	)	)	O	)	O	1	NMOD	0
5	is	be	B-VP	VBZ	O	0	ROOT	0
6	prominently	prominently	I-VP	RB	O	5	VMOD	0
7	up-regulated	up-regulate	I-VP	VBN	O	5	VC	17	up-regulated
8	in	in	B-PP	IN	O	7	VMOD	0
9	the	the	B-NP	DT	O	11	NMOD	0
10	host-derived	host-derived	I-NP	JJ	O	11	NMOD	0
11	vasculature	vasculature	I-NP	NN	O	8	PMOD	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	most	most	B-NP	JJS	O	14	NMOD	0
14	tumors	tumor	I-NP	NNS	O	12	PMOD	0
15	,	,	O	,	O	5	P	0
16	making	make	B-VP	VBG	O	5	VMOD	0
17	it	it	B-NP	PRP	O	20	SUB	0
18	an	an	B-NP	DT	O	20	NMOD	0
19	attractive	attractive	I-NP	JJ	O	20	NMOD	0
20	candidate	candidate	I-NP	NN	O	16	OBJ	0
21	for	for	B-PP	IN	O	20	NMOD	0
22	antiangiogenic	antiangiogenic	B-NP	JJ	O	23	NMOD	3	angiogenic
23	intervention	intervention	I-NP	NN	O	21	PMOD	18	intervention
24	.	.	O	.	O	5	P	0

1	Yet	Yet	B-ADVP	RB	O	12	VMOD	0
2	,	,	O	,	O	12	P	0
3	the	the	B-NP	DT	O	5	NMOD	0
4	net	net	I-NP	JJ	O	5	NMOD	0
5	outcome	outcome	I-NP	NN	O	12	SUB	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	Ang-2	Ang-2	B-NP	NN	B-protein	8	NMOD	0
8	functions	function	I-NP	NNS	O	6	PMOD	0
9	on	on	B-PP	IN	O	8	NMOD	0
10	tumor	tumor	B-NP	NN	O	11	NMOD	0
11	angiogenesis	angiogenesis	I-NP	NN	O	9	PMOD	3	angiogenesis
12	is	be	B-VP	VBZ	O	0	ROOT	0
13	believed	believe	I-VP	VBN	O	12	VC	0
14	to	to	I-VP	TO	O	15	VMOD	0
15	be	be	I-VP	VB	O	13	VMOD	0
16	contextual	contextual	B-ADJP	JJ	O	15	PRD	0
17	depending	depend	B-PP	VBG	O	16	AMOD	16	depending
18	on	on	B-PP	IN	O	17	PMOD	0
19	the	the	B-NP	DT	O	22	NMOD	0
20	local	local	I-NP	JJ	O	22	NMOD	0
21	cytokine	cytokine	I-NP	NN	O	22	NMOD	0
22	milieu	milieu	I-NP	NN	O	18	PMOD	0
23	.	.	O	.	O	12	P	0

1	Correspondingly	Correspondingly	B-ADVP	RB	O	6	VMOD	0
2	,	,	O	,	O	6	P	0
3	Ang-2	Ang-2	B-NP	NN	B-protein	5	NMOD	0
4	manipulatory	manipulatory	I-NP	JJ	O	5	NMOD	0
5	therapies	therapy	I-NP	NNS	O	6	SUB	0
6	have	have	B-VP	VBP	O	0	ROOT	0
7	been	be	I-VP	VBN	O	6	VC	0
8	shown	show	I-VP	VBN	O	7	VC	0
9	to	to	I-VP	TO	O	10	VMOD	0
10	exert	exert	I-VP	VB	O	8	VMOD	0
11	protumorigenic	protumorigenic	O	JJ	O	16	NMOD	0
12	as	as	B-CONJP	RB	O	16	NMOD	0
13	well	well	I-CONJP	RB	O	12	DEP	0
14	as	as	I-CONJP	IN	O	12	DEP	0
15	antitumorigenic	antitumorigenic	B-NP	JJ	O	16	NMOD	0
16	effects	effect	I-NP	NNS	O	10	OBJ	0
17	.	.	O	.	O	6	P	0

1	To	To	B-VP	TO	O	2	VMOD	0
2	clarify	clarify	I-VP	VB	O	22	VMOD	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	role	role	I-NP	NN	O	2	OBJ	16	role
5	of	of	B-PP	IN	O	4	NMOD	0
6	Ang-2	Ang-2	B-NP	NN	B-protein	5	PMOD	0
7	for	for	B-PP	IN	O	4	NMOD	0
8	angiogenesis	angiogenesis	B-NP	NN	O	11	NMOD	3	angiogenesis
9	and	and	I-NP	CC	O	11	NMOD	0
10	tumor	tumor	I-NP	NN	O	11	NMOD	0
11	growth	growth	I-NP	NN	O	7	PMOD	4	growth
12	in	in	B-PP	IN	O	4	NMOD	0
13	a	a	B-NP	DT	O	17	NMOD	0
14	definite	definite	I-NP	JJ	O	17	NMOD	0
15	genetic	genetic	I-NP	JJ	O	17	NMOD	0
16	experimental	experimental	I-NP	JJ	O	17	NMOD	0
17	setting	setting	I-NP	NN	O	12	PMOD	0
18	,	,	O	,	O	22	P	0
19	the	the	B-NP	DT	O	21	NMOD	0
20	present	present	I-NP	JJ	O	21	NMOD	0
21	study	study	I-NP	NN	O	22	SUB	0
22	was	be	B-VP	VBD	O	0	ROOT	0
23	aimed	aim	I-VP	VBN	O	22	VC	0
24	at	at	B-PP	IN	O	23	VMOD	0
25	comparatively	comparatively	B-VP	RB	O	26	VMOD	0
26	studying	study	I-VP	VBG	O	24	PMOD	0
27	the	the	B-NP	DT	O	28	NMOD	0
28	growth	growth	I-NP	NN	O	26	OBJ	4	growth
29	of	of	B-PP	IN	O	28	NMOD	0
30	different	different	B-NP	JJ	O	31	NMOD	0
31	tumors	tumor	I-NP	NNS	O	29	PMOD	0
32	in	in	B-PP	IN	O	31	NMOD	0
33	wild-type	wild-type	B-NP	JJ	O	36	NMOD	0
34	and	and	I-NP	CC	O	36	NMOD	0
35	Ang-2-deficient	Ang-2-deficient	I-NP	JJ	O	36	NMOD	9	deficient
36	mice	mouse	I-NP	NNS	O	32	PMOD	0
37	.	.	O	.	O	22	P	0

1	Lewis	Lewis	B-NP	NNP	O	3	NMOD	0
2	lung	lung	I-NP	NN	O	3	NMOD	0
3	carcinomas	carcinoma	I-NP	NNS	O	10	NMOD	0
4	,	,	O	,	O	10	P	0
5	MT-ret	MT-ret	B-NP	NN	O	6	NMOD	0
6	melanomas	melanoma	I-NP	NNS	O	10	NMOD	0
7	,	,	O	,	O	10	P	0
8	and	and	O	CC	O	10	NMOD	0
9	B16F10	B16F10	B-NP	NN	O	10	NMOD	0
10	melanomas	melanoma	I-NP	NNS	O	12	SUB	0
11	all	all	O	DT	O	12	VMOD	0
12	grew	grow	B-VP	VBD	O	0	ROOT	4	grew
13	slower	slow	B-ADJP	JJR	O	12	PRD	0
14	in	in	B-PP	IN	O	13	AMOD	0
15	Ang-2-deficient	Ang-2-deficient	B-NP	JJ	O	16	NMOD	9	deficient
16	mice	mouse	I-NP	NNS	O	14	PMOD	0
17	.	.	O	.	O	12	P	0

1	Yet	Yet	B-ADVP	RB	O	18	VMOD	0
2	,	,	O	,	O	18	P	0
3	tumor	tumor	B-NP	NN	O	4	NMOD	0
4	growth	growth	I-NP	NN	O	18	VMOD	4	growth
5	in	in	B-PP	IN	O	4	NMOD	0
6	wild-type	wild-type	B-NP	JJ	O	9	NMOD	0
7	and	and	I-NP	CC	O	9	NMOD	0
8	Ang-2-deficient	Ang-2-deficient	I-NP	JJ	O	9	NMOD	9	deficient
9	mice	mouse	I-NP	NNS	O	5	PMOD	0
10	dissociated	dissociate	B-VP	VBN	O	9	NMOD	0
11	during	during	B-PP	IN	O	10	VMOD	0
12	early	early	B-NP	JJ	O	13	NMOD	0
13	stages	stage	I-NP	NNS	O	11	PMOD	0
14	of	of	B-PP	IN	O	13	NMOD	0
15	tumor	tumor	B-NP	NN	O	16	NMOD	0
16	development	development	I-NP	NN	O	14	PMOD	2	development
17	,	,	O	,	O	18	P	0
18	whereas	whereas	O	IN	O	0	ROOT	0
19	tumor	tumor	B-NP	NN	O	21	NMOD	0
20	growth	growth	I-NP	NN	O	21	NMOD	4	growth
21	rates	rate	I-NP	NNS	O	29	SUB	0
22	during	during	B-PP	IN	O	21	NMOD	0
23	later	later	B-NP	JJ	O	24	NMOD	0
24	stages	stage	I-NP	NNS	O	22	PMOD	0
25	of	of	B-PP	IN	O	24	NMOD	0
26	primary	primary	B-NP	JJ	O	28	NMOD	0
27	tumor	tumor	I-NP	NN	O	28	NMOD	0
28	progression	progression	I-NP	NN	O	25	PMOD	2	progression
29	were	be	B-VP	VBD	O	18	VMOD	0
30	similar	similar	B-ADJP	JJ	O	29	PRD	0
31	.	.	O	.	O	18	P	0

1	Analysis	Analysis	B-NP	NN	O	7	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	0
3	the	the	B-NP	DT	O	6	NMOD	0
4	intratumoral	intratumoral	I-NP	JJ	O	6	NMOD	0
5	vascular	vascular	I-NP	JJ	O	6	NMOD	0
6	architecture	architecture	I-NP	NN	O	2	PMOD	0
7	revealed	reveal	B-VP	VBD	O	0	ROOT	0
8	no	no	B-NP	DT	O	10	NMOD	0
9	major	major	I-NP	JJ	O	10	NMOD	0
10	differences	difference	I-NP	NNS	O	7	OBJ	0
11	in	in	B-PP	IN	O	10	NMOD	0
12	microvessel	microvessel	B-NP	NN	O	13	NMOD	0
13	density	density	I-NP	NN	O	16	NMOD	0
14	and	and	I-NP	CC	O	16	NMOD	0
15	perfusion	perfusion	I-NP	NN	O	16	NMOD	14	perfusion
16	characteristics	characteristic	I-NP	NNS	O	11	PMOD	0
17	.	.	O	.	O	7	P	0

1	However	However	B-ADVP	RB	O	7	VMOD	0
2	,	,	O	,	O	7	P	0
3	diameters	diameter	B-NP	NNS	O	7	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	intratumoral	intratumoral	B-NP	JJ	O	6	NMOD	0
6	microvessels	microvessel	I-NP	NNS	O	4	PMOD	0
7	were	be	B-VP	VBD	O	19	VMOD	0
8	smaller	small	B-ADJP	JJR	O	7	PRD	0
9	in	in	B-PP	IN	O	8	AMOD	0
10	tumors	tumor	B-NP	NNS	O	9	PMOD	0
11	grown	grow	B-VP	VBN	O	10	NMOD	4	grown
12	in	in	B-PP	IN	O	11	VMOD	0
13	Ang-2-deficient	Ang-2-deficient	B-NP	JJ	O	14	NMOD	9	deficient
14	mice	mouse	I-NP	NNS	O	12	PMOD	0
15	,	,	O	,	O	19	P	0
16	and	and	O	CC	O	19	VMOD	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	vasculature	vasculature	I-NP	NN	O	19	SUB	0
19	had	have	B-VP	VBD	O	0	ROOT	0
20	an	an	B-NP	DT	O	22	NMOD	0
21	altered	altered	I-NP	JJ	O	22	NMOD	0
22	pattern	pattern	I-NP	NN	O	19	OBJ	0
23	of	of	B-PP	IN	O	22	NMOD	0
24	pericyte	pericyte	B-NP	NN	O	25	NMOD	0
25	recruitment	recruitment	I-NP	NN	O	27	NMOD	14	recruitment
26	and	and	I-NP	CC	O	27	NMOD	0
27	maturation	maturation	I-NP	NN	O	23	PMOD	2	maturation
28	.	.	O	.	O	19	P	0

1	Ang-2-deficient	Ang-2-deficient	B-NP	JJ	O	3	NMOD	9	deficient
2	tumor	tumor	I-NP	NN	O	3	NMOD	0
3	vessels	vessel	I-NP	NNS	O	4	SUB	0
4	had	have	B-VP	VBD	O	0	ROOT	0
5	higher	high	B-NP	JJR	O	8	NMOD	0
6	pericyte	pericyte	I-NP	NN	O	8	NMOD	0
7	coverage	coverage	I-NP	NN	O	8	NMOD	0
8	indices	index	I-NP	NNS	O	4	OBJ	0
9	.	.	O	.	O	4	P	0

1	Recruited	Recruit	B-NP	VBN	O	2	NMOD	14	Recruited
2	pericytes	pericyte	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	0	ROOT	0
4	desmin	desmin	B-NP	NN	O	12	NMOD	0
5	and	and	I-NP	CC	O	12	NMOD	0
6	NG2	NG2	I-NP	NN	B-protein	12	NMOD	0
7	positive	positive	I-NP	JJ	O	12	NMOD	0
8	and	and	I-NP	CC	O	12	NMOD	0
9	predominately	predominately	I-NP	RB	O	10	AMOD	0
10	alpha-smooth	alpha-smooth	I-NP	JJ	B-protein	12	NMOD	0
11	muscle	muscle	I-NP	NN	I-protein	12	NMOD	0
12	actin	actin	I-NP	NN	I-protein	3	PRD	0
13	negative	negative	B-ADJP	JJ	O	15	AMOD	0
14	,	,	O	,	O	15	P	0
15	indicative	indicative	B-ADJP	JJ	O	12	NMOD	0
16	of	of	B-PP	IN	O	15	AMOD	0
17	a	a	B-NP	DT	O	21	NMOD	0
18	more	more	I-NP	RBR	O	19	AMOD	0
19	mature	mature	I-NP	JJ	O	21	NMOD	0
20	pericyte	pericyte	I-NP	NN	O	21	NMOD	0
21	phenotype	phenotype	I-NP	NN	O	16	PMOD	0
22	.	.	O	.	O	3	P	0

1	Collectively	Collectively	B-ADVP	RB	O	5	VMOD	0
2	,	,	O	,	O	5	P	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	experiments	experiment	I-NP	NNS	O	5	SUB	0
5	define	define	B-VP	VBP	O	0	ROOT	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	role	role	I-NP	NN	O	5	OBJ	16	role
8	of	of	B-PP	IN	O	7	NMOD	0
9	Ang-2	Ang-2	B-NP	NN	B-protein	8	PMOD	0
10	during	during	B-PP	IN	O	7	NMOD	0
11	tumor	tumor	B-NP	NN	O	12	NMOD	0
12	angiogenesis	angiogenesis	I-NP	NN	O	10	PMOD	3	angiogenesis
13	and	and	O	CC	O	5	VMOD	0
14	establish	establish	B-VP	VB	O	5	VMOD	0
15	a	a	B-NP	DT	O	17	NMOD	0
16	better	good	I-NP	JJR	O	17	NMOD	0
17	rationale	rationale	I-NP	NN	O	14	OBJ	0
18	for	for	B-PP	IN	O	17	NMOD	0
19	combination	combination	B-NP	NN	O	20	NMOD	0
20	therapies	therapy	I-NP	NNS	O	18	PMOD	0
21	involving	involve	B-VP	VBG	O	20	NMOD	0
22	Ang-2	Ang-2	B-NP	NN	B-protein	24	NMOD	0
23	manipulatory	manipulatory	I-NP	JJ	O	24	NMOD	0
24	therapies	therapy	I-NP	NNS	O	21	OBJ	0
25	.	.	O	.	O	5	P	0

